Antiviral activity of natural and semisynthetic polysaccharides on the early steps of rubella virus infection

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 339-345

  Mastromarino, P ^a   Petruzziello, R ^a   Macchia, S ^a   Rieti, S ^a   Nicoletti, R ^b   Orsi, N ^a  

^a Institute of Microbiology   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGAROBA; ALGINIC ACID; DEXTRAN SULFATE; SCLEROGLUCAN;

ANTIVIRAL ACTIVITY; ARTICLE; INTERNALIZATION; RUBELLA VIRUS; VERO CELL; VIRUS ADSORPTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DEXTRAN SULFATE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GALACTANS; GLUCANS; GLYCOGEN; MANNANS; PLANT GUMS; PLAQUE ASSAY; POLYSACCHARIDES; RNA, VIRAL; RUBELLA; TRANSFECTION; VERO CELLS; VIRUS REPLICATION;

EID: 0030975572     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.339     Document Type: Article

References (21)

1. De Clercq, E. (1993). Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact. Advances in Virus Research 42, 1-55.
2. Ito, M., Baba, M., Sato, A., Pauwels, R., De Clercq, E. & Shigeta, S. (1987). Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Research 7, 361-7.
3. Ueno, R. & Kuno, S. (1987). Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet i, 1379.
4. Baba, M., Snoeck, R., Pauwels, R. & de Clercq, E. (1988). Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalo-virus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 32, 1742-5.
5. Schols, D., De Clercq, E., Balzarini, J., Baba, M., Witvrouw, M., Hosoya, M. et al. (1990). Sulphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses. Antiviral Chemistry and Chemotherapy 1, 233-40.
6. Aoki, T., Kaneko, Y., Stefanski, M. S., Nguyen, T. & Ting, R. C. Y. (1991). Curdlan sulfate and HIV-1.I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection. AIDS Research and Human Retroviruses 7, 409-15.
7. García-Villalón, D. & Gil-Fernández, C. (1991). Antiviral activity of sulfated polysaccharides against African swine fever virus. Antiviral Research 15, 139-48.
8. Parish, C. R., Low, L., Warren, H. S. & Cunningham, A. L. (1990). A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region. Journal of Immunology 145, 1188-95.
9. McClure, M. O., Moore, P. J., Blanc, D. F., Scotting, P., Cook, G, M. W., Keynes, R. J. et al. (1992). Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Research and Human Retroviruses 8, 19-26.
10. Bagasra, O. & Lischner, H. W. (1988). Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. Journal of Infectious Diseases 158, 1084-7.
11. Schols, D., Pauwels, R., Desmyter, J. & De Clercq, E. (1990). Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 175, 556-61.
12. Callahan, L. N., Phelan, M., Mallinson, M. & Norcross, M. A. (1991). Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 wlthout interfering with gp120-CD4 interactions. Journal of Virology 65, 1543-50.
13. Mastromarino, P., Cioé, L., Rieti, S. & Orsi, N. (1990). Role of membrane phospholipids and glycolipids in the Vero cell surface receptor for rubella virus. Medical Microbiology and Immunology 179, 105-14.
14. Sawicki, S. G., Sawicki, D. L., Kääriäinen, L. & Keränen, S. (1981). A Sindbis virus mutant temperature-sensitive in the regulation of minus-strand RNA synthesis. Virology 115, 161-72.
15. Petruzziello, R., Orsi, N., Macchia, S., Rieti, S., Frey, T. K. & Mastromarino, P. (1996). Pathway of rubella virus infectious entry into Vero cells. Journal of General Virology 77, 303-8.
16. Aspinall, G. O. (1983). Classification of polysaccharides. In The Polysaccharides, Vol. 2 (Aspinall, G. O., Ed.), pp. 1-9. Academic Press, New York, NY.
17. Shannon, W. M. (1984). Mechanisms of action and pharmacology: chemical agents. In Antiviral Agents and Viral Diseases of Man, 2nd edn (Galasso, G. J., Merigan, T. C. & Buchanan, R. A., Eds), pp. 55-121. Raven Press, New York, NY.
18. González, M. E., Alarcón, B. & Carrasco, L. (1987). Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrobial Agents and Chemotherapy 31, 1388-93.
19. Pietropaolo, V., Seganti, L, Marchetti, M., Sinibaldi, L, Orsi, N. & Nicoletti, R. (1993). Effect of natural and semisynthetic polymers on rabies virus infection in CER cells. Research in Virology 144, 151-8.
20. Marchetti, M., Pisani, S., Pietropaolo, V., Seganti, L., Nicoletti, R., Orsi, N. (1995). Inhibition of herpes simplex virus infection by negatively charged and neutral carbohydrate polymers. Journal of Chemotherapy 7, 90-6.
21. Pretus, H. A., Ensley, H. E., McNamee, R. B., Jones, E. L., Browder, I. W. & Williams, D. L. (1991). Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. Journal of Pharmacology and Experimental Therapeutics 257, 500-10.